Alcohol
Volume 27, Issue 3 , Pages 163-167 , July 2002

S-Adenosylmethionine revisited: its essential role in the regulation of liver function

Received 4 February 2002 ,Revised 25 March 2002 ,Accepted 28 March 2002.

References 

  1. Avila MA, Berasain C, Torres L, Martı́n-Duce A, Corrales FJ, Yang H, et al. Reduced mRNA abundance of the main enzymes involved in methionine metabolism in human liver cirrhosis and hepatocellular carcinoma. J Hepatol. 2000;33:907–914
  2. Avila MA, Carretero MV, Rodrı́guez EN, Mato JM. Regulation by hypoxia of methionine adenosyltransferase activity and gene expression in rat hepatocytes. Gastroenterology. 1998;114:364–371
  3. Avila MA, Mingorance J, Martı́nez-Chantar ML, Casado M, Martin-Sanz P, Boscá L, et al. Regulation of rat liver S-adenosylmethionine synthetase during septic shock (role of nitric oxide). Hepatology. 1997;25:391–396
  4. Barak AJ, Beckenhauer HC, Tuma DJ, Badakhsh S. Effects of prolonged ethanol feeding on methionine metabolism in rat liver. Biochem Cell Biol. 1987;65:230–233
  5. Bjarnason I, Peters TJ, Wise RJ. The leaky gut of alcoholism (a possible route of entry of toxic compounds). Lancet. 1984;1:179–182
  6. Cabrero C, Martı́n-Duce AM, Ortiz P, Alemany S, Mato JM. Specific loss of the high-molecular-weight form of S-adenosyl-l-methionine synthetase in human liver cirrhosis. Hepatology. 1988;8:1530–1534
  7. Cai J, Mao Z, Hwang JJ, Lu SC. Differential expression of methionine adenosyltransferase genes influences the rate of growth of human hepatocellular carcinoma cells. Cancer Res. 1998;58:1444–1450
  8. Cai J, Sun WM, Hwang JJ, Stain SC, Lu SC. Changes in S-adenosylmethionine synthetase in human liver cancer (molecular characterization and significance). Hepatology. 1996;24:1090–1097
  9. Carretero MV, Latasa MU, Garcı́a-Trevijano ER, Corrales FJ, Wagner C, Mato JM, et al. Inhibition of liver methionine adenosyltransferase gene expression by 3-methylcolanthrene (protective effect of S-adenosylmethionine). Biochem Pharmacol. 2001;61:1119–1128
  10. Chawla RK, Bonkovsky HL, Galambos JT. Biochemistry and pharmacology of S-adenosyl-l-methionine and rationale for its use in liver disease. Drugs. 1990;40(Suppl 3):98–110
  11. Corrales F, Giménez A, Alvarez L, Caballerı́a J, Pajares MA, Andreu H, et al. S-adenosylmethionine treatment prevents carbon tetrachloride–induced S-adenosylmethionine synthetase inactivation and attenuates liver injury. Hepatology. 1992;16:1022–1027
  12. Corrales F, Ochoa P, Rivas C, Martı́n-Lomas M, Mato JM, Pajares MA. Inhibition of glutathione synthesis in the liver leads to S-adenosyl-l-methionine synthetase reduction. Hepatology. 1991;14:528–533
  13. Corrales FJ, Ruiz F, Mato JM. In vivo regulation by glutathione of methionine adenosyltransferase S-nitrosylation in rat liver. J Hepatol. 1999;31:887–894
  14. Finkelstein JD. Methionine metabolism in mammals. J Nutr Biochem. 1990;1:228–236
  15. Frezza M. A meta-analysis of therapeutic trials with ademethionine in the treatment of intrahepatic cholestasis. Ann Ital Med Int. 1993;8(Suppl):48S–51S
  16. Frezza M, Surrenti C, Manzillo G, Fiaccadori F, Bortolini M, Di Padova C. Oral S-adenosylmethionine in the symptomatic treatment of intrahepatic cholestasis. A double-blind, placebo-controlled study. Gastroenterology. 1990;99:211–215
  17. Garcea R, Daino L, Pascale R, Simile MM, Puddu M, Frassetto S, et al. Inhibition of promotion and persistent nodule growth by S-adenosyl-l-methionine in rat liver carcinogenesis (role of remodeling and apoptosis). Cancer Res. 1989;49:1850–1856
  18. Garcı́a-Ruiz C, Morales A, Colell A, Ballesta A, Rodes J, Kaplowitz N, et al. Feeding S-adenosyl-l-methionine attenuates both ethanol-induced depletion of mitochondrial glutathione and mitochondrial dysfunction in periportal and perivenous rat hepatocytes. Hepatology. 1995;21:207–214
  19. Garcı́a-Trevijano ER, Latasa MU, Carretero MV, Berasain C, Mato JM, Avila MA. S-Adenosylmethionine regulates MAT1A and MAT2A gene expression in cultured rat hepatocytes (a new role for S-adenosylmethionine in the maintenance of the differentiated status of the liver). FASEB J. 2000;14:2511–2518
  20. Gil B, Casado M, Pajares MA, Boscá L, Mato JM, Martin-Sanz P, et al. Differential expression pattern of S-adenosylmethionine synthetase isoenzymes during rat liver development. Hepatology. 1996;24:876–881
  21. Holm E, Sedlaczek O, Grips E. Amino acid metabolism in liver disease. Curr Opin Clin Nutr Metab Care. 1999;2:47–53
  22. Horowitz JH, Rypins EB, Henderson JM, Heymsfield SB, Moffitt SD, Bain RP, et al. Evidence for impairment of transsulfuration pathway in cirrhosis. Gastroenterology. 1981;81:668–675
  23. Huang ZZ, Mao Z, Cai J, Lu SC. Changes in methionine adenosyltransferase during liver regeneration in the rat. Am J Physiol. 1998;275:G14–G21
  24. Kinsell LW, Harper HA, Marton HC, Michael GD, Weiss HA. Rate of disappearance from plasma of intravenously administered methionine in patients with liver damage. Science. 1947;106:589–590
  25. Kotb M, Geller AM. Methionine adenosyltransferase (structure and function). Pharmacol Ther. 1993;59:125–143
  26. Kotb M, Mudd SH, Mato JM, Geller AM, Kredich NM, Chou JY, et al. Consensus nomenclature for the mammalian methionine adenosyltransferase genes and gene products. Trends Genet. 1997;13:51–52
  27. Krahenbuhl S. Carnitine metabolism in chronic liver disease. Life Sci. 1996;59:1579–1599
  28. Krahenbuhl S, Brass EP, Hoppel CL. Decreased carnitine biosynthesis in rats with secondary biliary cirrhosis. Hepatology. 2000;31:1217–1223
  29. Latasa MU, Boukaba A, Garcı́a-Trevijano ER, Torres L, Rodrı́guez JL, Caballerı́a J, et al. Hepatocyte growth factor induces MAT2A expression and histone acetylation in rat hepatocytes (role in liver regeneration). FASEB J. 2001;15:1248–1250
  30. LeGros HL, Halim AB, Geller AM, Kotb M. Cloning, expression, and functional characterization of the beta regulatory subunit of human methionine adenosyltransferase (MAT II). J Biol Chem. 2000;275:2359–2366
  31. Lieber CS. Cytochrome P-4502E1 (its physiological and pathological role). Physiol Rev. 1997;77:517–544
  32. Lieber CS. Prevention and treatment of liver fibrosis based on pathogenesis. Alcohol Clin Exp Res. 1999;23:944–999 a
  33. Lieber CS. Role of S-adenosyl-l-methionine in the treatment of liver diseases. J Hepatol. 1999;30:1155–1159 b
  34. Lieber CS, Casini A, DeCarli LM, Kim CI, Lowe N, Sasaki R, et al. S-adenosyl-l-methionine attenuates alcohol-induced liver injury in the baboon. Hepatology. 1990;11:165–172
  35. Lieber CS, Robins SJ, Leo MA. Hepatic phosphatidylethanolamine methyltransferase activity is decreased by ethanol and increased by phosphatidylcholine. Alcohol Clin Exp Res. 1994;18:592–595
  36. Lu SC, Alvarez L, Huang ZZ, Chen L, An W, Corrales FJ, et al. Methionine adenosyltransferase 1A knockout mice are predisposed to liver injury and exhibit increased expression of genes involved in proliferation. Proc Natl Acad Sci USA. 2001;98:5560–5565
  37. Lu SC, Huang ZZ, Yang H, Mato JM, Avila MA, Tsukamoto H. Changes in methionine adenosyltransferase and S-adenosylmethionine homeostasis in alcoholic rat liver. Am J Physiol Gastrointest Liver Physiol. 2000;279:G178–G185
  38. Majano PL, Garcı́a-Monzón C, Garcı́a-Trevijano ER, Corrales FJ, Cámara J, Ortiz P, et al. S-Adenosylmethionine modulates inducible nitric oxide synthase gene expression in rat liver and isolated hepatocytes. J Hepatol. 2001;35:692–699
  39. Marchesini G, Bugianesi E, Bianchi G, Fabbri A, Marchi E, Zoli M, et al. Defective methionine metabolism in cirrhosis (relation to severity of liver disease). Hepatology. 1992;16:149–155
  40. Martı́n-Duce A, Ortiz P, Cabrero C, Mato JM. S-Adenosyl-l-methionine synthetase and phospholipid methyltransferase are inhibited in human cirrhosis. Hepatology. 1988;8:65–68
  41. Mato JM, Alvarez L, Ortiz P, Pajares MA. S-adenosylmethionine synthesis (molecular mechanisms and clinical implications). Pharmacol Ther. 1997;73:265–280
  42. Mato JM, Avila MA, Corrales FJ. Biosynthesis of S-adenosylmethionine. In:  Carmel R,  Jacobsen DW editor. Homocysteine in Health and Disease. Cambridge, UK: Cambridge University Press; 2001;p. 47–62
  43. Mato JM, Cámara J, Fernández de Paz J, Caballerı́a L, Coll S, Caballero A, et al. S-adenosylmethionine in alcoholic liver cirrhosis (a randomized, placebo-controlled, double-blind, multicenter clinical trial). J Hepatol. 1999;30:1081–1089
  44. Mirpuri E, Garcı́a-Trevijano ER, Castilla-Cortázar I, Berasain C, Quiroga J, Rodriguez-Ortigosa C, et al. Altered liver gene expression in CCl4-cirrhotic rats is partially normalized by insulin-like growth factor-I. Int J Biochem Cell Biol. 2002;34:242–252
  45. Mudd SH, Poole JR. Labile methyl balances for normal humans on various dietary regimens. Metabolism. 1975;24:721–735
  46. Navder KP, Baraona E, Lieber CS. Polyenylphosphatidylcholine attenuates alcohol-induced fatty liver and hyperlipemia in rats. J Nutr. 1997;127:1800–1806
  47. Newberne PM, Rogers AE. Labile methyl groups and the promotion of cancer. Annu Rev Nutr. 1986;6:407–432
  48. Pascale RM, Marras V, Simile MM, Daino L, Pinna G, Bennati S, et al. Chemoprevention of rat liver carcinogenesis by S-adenosyl-l-methionine (a long-term study). Cancer Res. 1992;52:4979–4986
  49. Ruiz F, Corrales FJ, Miqueo C, Mato JM. Nitric oxide inactivates rat hepatic methionine adenosyltransferase in vivo by S-nitrosylation. Hepatology. 1998;28:1051–1057
  50. Sánchez-Góngora E, Ruiz F, Mingorance J, An W, Corrales FJ, Mato JM. Interaction of liver methionine adenosyltransferase with hydroxyl radical. FASEB J. 1997;11:1013–1019
  51. Schuetz EG, Li D, Omiecinski CJ, Muller-Eberhard U, Kleinman HK, Elswick B, et al. Regulation of gene expression in adult rat hepatocytes cultured on a basement membrane matrix. J Cell Physiol. 1988;134:309–323
  52. Torres L, Avila MA, Carretero MV, Latasa MU, Caballerı́a J, López-Rodas G, et al. Liver-specific methionine adenosyltransferase MAT1A gene expression is associated with a specific pattern of promoter methylation and histone acetylation (implications for MAT1A silencing during transformation). FASEB J. 2000;14:95–102
  53. Trimble KC, Molloy AM, Scott JM, Weir DG. The effect of ethanol on one-carbon metabolism (increased methionine catabolism and lipotrope methyl-group wastage). Hepatology. 1993;18:984–989
  54. Varela-Moreiras G, Alonso-Aperte E, Rubio M, Gassó M, Deulofeu R, Alvarez L, et al. Carbon tetrachloride–induced hepatic injury is associated with global DNA hypomethylation and homocysteinemia (effect of S-adenosylmethionine treatment). Hepatology. 1995;22:1310–1315
  55. Vendemiale G, Altomare E, Trizio T, Le Grazie C, Di Padova C, Salerno MT, et al. Effects of oral S-adenosyl-l-methionine on hepatic glutathione in patients with liver disease. Scand J Gastroenterol. 1989;24:407–415
  56. Wainfan E, Dizik M, Stender M, Christman JK. Rapid appearance of hypomethylated DNA in livers of rats fed cancer-promoting, methyl-deficient diets. Cancer Res. 1989;49:4094–4097

☆ Editor: T.R. Jerrells

PII: S0741-8329(02)00228-8

Alcohol
Volume 27, Issue 3 , Pages 163-167 , July 2002

Article Tools